Answers are grounded in this paper and cite their sources.
New N-substituted hydrazine linkers were synthesized and their hydrazone derivatives of adriamycin were prepared. These functionalized adriamycin derivatives were conjugated with a monoclonal antibody, 5E9. The release rate of adriamycin from the hydrazones and from some of the conjugates was studied, and their relationship to the IC50's of the conjugate against 5E9-positive Daudi cells was investigated.
No takes yet. Share an insight, caveat, or question.
Kaneko et al. (1991) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: